An analyst turned pharma CEO learns the art of operations

Under Apurva Saraf’s guidance, Cosette Pharmaceuticals is pivoting wholeheartedly into the cardio space.

By Jared Whitlock • April 5, 2022

Clinical trial recruitment hits the local pharmacy counter

CVS Health's partnership with clinical trial software company Medable is designed to make recruitment easier for patients and drug makers alike.

By Kelly Bilodeau • April 5, 2022

Explore the Trendline➔

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

By PharmaVoice staff

Down but not out: How AVEO's CEO steered the company past an FDA rejection

Michael Bailey explains why focusing on the patient helped AVEO clear regulatory hurdles to bring a new cancer drug across the finish line.

By Kim Ribbink • April 5, 2022

Lessons from improv: Shankar Narayanan’s ‘yes, and’ approach to healthcare leadership

Real Chemistry's CEO is bringing a unique set of skills to the role as he sets off on a company-wide listening tour.

By Taren Grom • April 4, 2022

Time-saving tech lights Alcon's path into digital innovation

Kevin Yapp, global head or omni-channel transformation at the Swiss eye health company shares why the customer should be a  North Star when developing digital tools.

By Kim Ribbink • April 4, 2022

From media to menopause: Creating new spaces in women's telehealth

Why the former editor-in-chief of Marie Claire abandoned her magazine career to create a menopause-focused women's health startup.

By Alexandra Pecci • March 29, 2022

How a rock 'n' roll guru is putting a new spin on health education for patients

A former agent for The Rolling Stones has launched a healthcare streaming platform with a cast of entertainment heavyweights — and he wants pharma to be a headline act.

By Meagan Parrish • March 28, 2022

Rare Patient Voice's president is striving to create a five-star experience for patients

Successful clinical trial recruitment depends on listening to and empowering patients.

By Kim Ribbink • March 23, 2022

Woman of the Week: Merck's Dr. Mary-Ann Etiebet

The associate VP of health equity is on a quest to address the relationship between health, gender and economic opportunities.

By Taren Grom • March 23, 2022

Another pandemic threat looms, and the antibacterial drug pipeline still isn't keeping up

A recent report from BIO details challenges in the antibiotic market — and new policy measures that could help.

By Kelly Bilodeau • March 23, 2022

Why Astellas is adopting a 'focus area approach' to partnerships

Chief Strategy Officer, Naoki Okamura, explains why new trends and innovations require a different approach to alliances.

By Kim Ribbink • March 22, 2022

Psychedelics without the party: Inside MindMed's LSD makeover

MindMed’s CEO, Robert Barrow, on the company’s latest moves to ‘change the world’ with psychedelics.

By Alexandra Pecci • March 21, 2022

BioMarin’s new global head of advocacy is tackling the holy grail of patient engagement

In her new role, Dr. Roz is keeping her patient-first approach.

By Taren Grom • March 21, 2022

Virpax's CEO on leveraging new formulations to move drugs toward approval

Anthony Mack shares his lessons from getting unconventional pharma products across the finish line.

By Meagan Parrish • March 18, 2022

Civica Rx thinks it has a cure for high insulin prices

Civica’s president and CEO, Martin VanTrieste, explains the nonprofit’s aim to manufacture low-cost insulin — and which area of pharma it plans to target next.

By Kelly Bilodeau • March 16, 2022

How Novartis kept its supply chain intact during COVID-19

In an agile pivot, Amit Nastik led Novartis’ manufacturing operations through the pandemic without losing supply chain reliability. 

By Taren Grom • March 16, 2022

Woman of the Week: Ceek Women's Health CEO Fahti Khosrowshahi

Fahti Khosrowshahi, CEO and founder, Ceek Women’s Health, is designing award-winning products to change the face of women's health. 

By Taren Grom • March 16, 2022

COVID-19 trials aren't the only studies that can achieve super speed

Is it possible to enroll clinical trials 10 times faster than the industry’s average speed? Elligo Health Research thinks so.

By Kelly Bilodeau • March 15, 2022

Medigene's CEO on striking a collaboration deal with BioNTech

The two companies recently announced a $29 million collaboration. 

By Jared Whitlock • March 15, 2022

Clearing hurdles in rare cancer drug development

Rafael’s CEO, Sanjeev Luther, explains why flexibility and agility are keys to success in the rare cancer space.

By Kim Ribbink • March 14, 2022

Liquid biopsy is a multibillion-dollar market, and InterVenn is looking to take advantage

The company’s CEO explains how its liquid biopsy tests target a unique, untapped layer of biology.

By Taren Grom • March 14, 2022

Biote CEO: Employers need to normalize women's health issues in the workforce

A survey by Biote reveals the impact of menopause on working women.

By Robin Robinson • March 14, 2022

Ultragenyx's CEO on building a 'next-gen' rare disease company

How Dr. Emil Kakkis is maintaining the soul of a startup while undergoing growth.

By Kim Ribbink • March 9, 2022

From angel to operator: The unlikely journey of Endevica Bio's CEO

Russell Potterfield is honing his new found passion for the space to guide Endevica into the clinic.

By Jared Whitlock • March 9, 2022

Woman of the Week: Genentech's Quita Highsmith

Quita Highsmith is changing how Genentech approaches diversity and inclusion across the board — from drug development to career advancement.

By Taren Grom • March 9, 2022